<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38333536</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2589-5370</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><PubDate><Year>2024</Year><Month>Feb</Month></PubDate></JournalIssue><Title>EClinicalMedicine</Title><ISOAbbreviation>EClinicalMedicine</ISOAbbreviation></Journal><ArticleTitle>How does post COVID differ from other post-viral conditions in childhood and adolescence (0-20 years old)? A systematic review.</ArticleTitle><Pagination><StartPage>102436</StartPage><MedlinePgn>102436</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102436</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eclinm.2024.102436</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Post Coronavirus disease (COVID) and other post-viral infection syndromes present an overlap of pathogenesis, onset, progression, and symptom profile. We aimed to systematically describe studies on post-viral conditions and determine the entity of post COVID compared to other post-viral conditions in children.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We conducted a systematic search of the Embase, MEDLINE, Cochrane Library, and GoogleScholar databases (January 1946-3 November 2023), according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. The main outcomes were differences in condition duration, symptom type, and development of chronic symptoms. This systematic review was registered on PROSPERO (CRD42023401789).</AbstractText><AbstractText Label="FINDINGS" NlmCategory="UNASSIGNED">35/5051 studies were included, with 42,934 children, adolescents and young adults (0-20 years old) overall. Twenty-eight studies focused on post COVID symptoms, followed by five papers on Respiratory Syncytial Virus (RSV) and Rhinovirus, one study on Epstein-Barr Virus (EBV), and one on gastrointestinal viruses. Studies on post COVID mainly reported data on older children/adolescents, describing long-lasting symptoms, including fatigue, neurologic, cardiorespiratory, musculoskeletal, mental health, and gastrointestinal symptoms. The maximum described symptoms duration was eighteen months, with an average follow-up of seven months. The development of chronic symptoms was reported by 30 studies (93.8%) for 10,473/28,474 patients (36.8%). Recovery was achieved in 18,001/28,474 cases (63.2%). The study on EBV reported persistent fatigue in adolescents for a similar duration (6 months, 46% chronic). Studies on RSV and Rhinovirus were mainly done in children under three years, with development of recurrent wheezing (up to 3 years).</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">Post-viral fatigue was a shared feature between post COVID and post EBV conditions. A better understanding of post COVID as a unique condition, sharing features with other post-viral syndromes, is needed. The healthcare burden and socio-economic consequences for children and their families warrant further investigation and development of appropriate healthcare management plans. The foremost requirement is the establishment of consistent and shareable definitions, as well as a consensus on outcomes, to effectively evaluate follow-up and quantify the burden of different viral infections.</AbstractText><AbstractText Label="FUNDING" NlmCategory="UNASSIGNED">EU Horizon, EDCTP, NIH.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Minotti</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Women's and Children's Health, University of Padua, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>PhD Program in Clinical Research, University Children's Hospital Basel, University of Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKenzie</LastName><ForeName>Carla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Desmond Tutu TB Centre, Department of Pediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dewandel</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Desmond Tutu TB Centre, Department of Pediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bekker</LastName><ForeName>Carien</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Desmond Tutu TB Centre, Department of Pediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sturniolo</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Women's and Children's Health, University of Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doni</LastName><ForeName>Denis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Women's and Children's Health, University of Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giaquinto</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Women's and Children's Health, University of Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Der Zalm</LastName><ForeName>Marieke M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Desmond Tutu TB Centre, Department of Pediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Don&#xe0;</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Women's and Children's Health, University of Padua, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K43 TW011028</GrantID><Acronym>TW</Acronym><Agency>FIC NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EClinicalMedicine</MedlineTA><NlmUniqueID>101733727</NlmUniqueID><ISSNLinking>2589-5370</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adolescents</Keyword><Keyword MajorTopicYN="N">Children</Keyword><Keyword MajorTopicYN="N">Chronic symptoms</Keyword><Keyword MajorTopicYN="N">EBV</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post-viral condition</Keyword></KeywordList><CoiStatement>The Authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>9</Day><Hour>4</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38333536</ArticleId><ArticleId IdType="pmc">PMC10850405</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2024.102436</ArticleId><ArticleId IdType="pii">S2589-5370(24)00015-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zimmermann P., Pittet L.F., Curtis N. How common is long COVID in children and adolescents? Pediatr Infect Dis J. 2021;40(12):e482&#x2013;e487. doi: 10.1097/INF.0000000000003328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003328</ArticleId><ArticleId IdType="pmc">PMC8575095</ArticleId><ArticleId IdType="pubmed">34870392</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Post COVID-19 condition (Long COVID) (who.int), 2022. Last accessed 23rd November 2023.</Citation></Reference><Reference><Citation>Long COVID or post-COVID conditions&#x2016;CDC, 2023. Last accessed 23rd November 2023.</Citation></Reference><Reference><Citation>Guideline COVID-19 rapid guideline: managing the long-term effects of COVID-19 (nice.org.UK)], 2021. Last accessed 23rd November 2023.</Citation></Reference><Reference><Citation>Bannister B.A. Post-infectious disease syndrome. Postgrad Med J. 1988;64(753):559&#x2013;567. doi: 10.1136/pgmj.64.753.559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.64.753.559</ArticleId><ArticleId IdType="pmc">PMC2428896</ArticleId><ArticleId IdType="pubmed">3074289</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J., Jansari V., Hornig M., Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. 2022;28:911&#x2013;923.</Citation><ArticleIdList><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Archer M.I. The post-viral syndrome: a review. J&#xa0;R Coll Gen Pract. 1987;37(298):212&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1710789</ArticleId><ArticleId IdType="pubmed">3320358</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss-Morris R., Deary V., Castell B. Chronic fatigue syndrome. Handb Clin Neurol. 2013;110:303&#x2013;314. doi: 10.1016/B978-0-444-52901-5.00025-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-52901-5.00025-3</ArticleId><ArticleId IdType="pubmed">23312650</ArticleId></ArticleIdList></Reference><Reference><Citation>Colby J. Special problems of children with myalgic encephalomyelitis/chronic fatigue syndrome and the enteroviral link. J&#xa0;Clin Pathol. 2006;60(2):125&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1860612</ArticleId><ArticleId IdType="pubmed">16935964</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdoch J.C. Post-viral syndrome. J&#xa0;R Coll Gen Pract. 1987;37(304)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1711121</ArticleId><ArticleId IdType="pubmed">2851046</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L., Lipkin W.I. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol Med. 2021;27(9):895&#x2013;906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukocheva O.A., Maksoud R., Beeraka N.M., et al. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome. J&#xa0;Adv Res. 2022;40</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8619886</ArticleId><ArticleId IdType="pubmed">36100326</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace P.G. Post-viral fatigue syndrome. Epidemiology: a critical review. Br Med Bull. 1991;47(4):942&#x2013;951.</Citation><ArticleIdList><ArticleId IdType="pubmed">1794092</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins R. Epidemiology: lessons from the past. Br Med Bull. 1991;47(4):952&#x2013;965.</Citation><ArticleIdList><ArticleId IdType="pubmed">1794093</ArticleId></ArticleIdList></Reference><Reference><Citation>Capelli E., Zola R., Lorusso L., Venturini L., Sardi F., Ricevuti G. Chronic fatigue syndrome/myalgic encephalomyelitis: an update. Int J Immunopathol Pharmacol. 2010;23(4):981&#x2013;989.</Citation><ArticleIdList><ArticleId IdType="pubmed">21244747</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes Rivera M., Mastronardi C., Silva-Aldana C., Arcos-Burgos M., Lidbury B. Myalgic encephalomyelitis/chronic fatigue syndrome: a comprehensive review. Diagnostics. 2019;9(3):91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6787585</ArticleId><ArticleId IdType="pubmed">31394725</ArticleId></ArticleIdList></Reference><Reference><Citation>Behan P.O., Behan W.M. Postviral fatigue syndrome. Crit Rev Neurobiol. 1988;4(2)</Citation><ArticleIdList><ArticleId IdType="pubmed">3063394</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L.A., Yoo S., Bhatia S. Patient perceptions of infectious illnesses preceding myalgic encephalomyelitis/chronic fatigue syndrome. Chronic Illn. 2022;18(4):901&#x2013;910.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9152619</ArticleId><ArticleId IdType="pubmed">34541918</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzigallo E., Racciatti D., Gorgoretti V. Ebv CHRONIC infections. Mediterr J Hematol Infect Dis. 2010;2(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3033110</ArticleId><ArticleId IdType="pubmed">21415952</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., et al. Characterising long COVID: a living systematic review. BMJ Global Health. 2021;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippatos F., Tatsi E.B., Michos A. Post-COVID-19 syndrome in children (Review) Exp Ther Med. 2022;24(4):609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9468832</ArticleId><ArticleId IdType="pubmed">36160884</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Di Gennaro L., De Rose C., et al. Long-Term outcomes of pediatric infections: from traditional infectious diseases to long Covid. Future Microbiol. 2022;17:551&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8910780</ArticleId><ArticleId IdType="pubmed">35264003</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandler C.X., Wyller V.B.B., Moss-Morris R., et al. Long COVID and post-infective fatigue syndrome: a review. Open Forum Infect Dis. 2021;8(10)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8496765</ArticleId><ArticleId IdType="pubmed">34631916</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E., Sudre C.H., Canas L.S., et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health. 2021;5(10):708&#x2013;718. doi: 10.1016/S2352-4642(21)00198-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00198-X</ArticleId><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A., Altman D.G., Tetzlaff J., et al. The PRISMA statement for reporting systematic reviews and metaanalyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. doi: 10.1136/bmj.b2700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2700</ArticleId><ArticleId IdType="pmc">PMC2714672</ArticleId><ArticleId IdType="pubmed">19622552</ArticleId></ArticleIdList></Reference><Reference><Citation>National Heart Lung and Blood Institute Quality assessment tool for observational cohort and cross-sectional studies. Bethesda, MD: Natl Institutes Heal Dep Heal Hum Serv (2014). P. 1&#x2013;4 Chia JKS. The role of enterovirus in chronic fatigue syndrome. J&#xa0;Clin Pathol. 2005;58(11):1126&#x2013;1132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1770761</ArticleId><ArticleId IdType="pubmed">16254097</ArticleId></ArticleIdList></Reference><Reference><Citation>Smane L., Stars I., Pucuka Z., et al. Persistent clinical features in paediatric patients after SARS-CoV-2 virological recovery: a retrospective population-based cohort study from a single centre in Latvia. BMJ Paediatrics Open. 2020;4 doi: 10.1136/bmjpo-2020-000905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjpo-2020-000905</ArticleId><ArticleId IdType="pmc">PMC7778738</ArticleId><ArticleId IdType="pubmed">34192185</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterky E., Olsson-&#xc5;kefeldt S., Hertting O., et al. Persistent symptoms in Swedish children after hospitalisation due to COVID-19. Acta Paediatr. 2021;110(9):2578&#x2013;2580. doi: 10.1111/apa.15999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15999</ArticleId><ArticleId IdType="pmc">PMC8444740</ArticleId><ArticleId IdType="pubmed">34157167</ArticleId></ArticleIdList></Reference><Reference><Citation>Roessler M., Tesch F., Batram M., et al. Post-COVID-19-associated morbidity in children, adolescents, and adults: a matched cohort study including more than 157,000 individuals with COVID-19 in Germany. PLoS Med. 2022;19(11) doi: 10.1371/journal.pmed.1004122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004122</ArticleId><ArticleId IdType="pmc">PMC9648706</ArticleId><ArticleId IdType="pubmed">36355754</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L., Holm M., Knudsen M., Ellermann-Eriksen S., Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children&#x2014;a nationwide cohort study. Eur J Pediatr. 2022;181:1597&#x2013;1607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gennaro L., Valentini P., Sorrentino S., et al. Extended coagulation profile of children with Long Covid: a prospective study. Sci Rep. 2022;12 doi: 10.1038/s41598-022-23168-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-23168-y</ArticleId><ArticleId IdType="pmc">PMC9626616</ArticleId><ArticleId IdType="pubmed">36319840</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Aumatell A., Bovo M.V., Carreras-Abad C., et al. Social, academic, and health status impact of long COVID on children and young people: an observational, descriptive, and longitudinal cohort study. Children. 2022;9(11):1677. doi: 10.3390/children9111677.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children9111677</ArticleId><ArticleId IdType="pmc">PMC9689050</ArticleId><ArticleId IdType="pubmed">36360405</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello R., Mariani F., Mastrantoni L., et al. Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort study. eClinicalMedicine. 2023;59 doi: 10.1016/j.eclinm.2023.101961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101961</ArticleId><ArticleId IdType="pmc">PMC10101848</ArticleId><ArticleId IdType="pubmed">37073325</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikkenborg Berg S., Palm P., Nygaard U., et al. A.&#xa0;Long COVID symptoms in SARS-CoV-2-positive children aged 0-14 years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study. Lancet Child Adolesc Health. 2022;6(9):614&#x2013;623. doi: 10.1016/S2352-4642(22)00154-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00154-7</ArticleId><ArticleId IdType="pmc">PMC9221683</ArticleId><ArticleId IdType="pubmed">35752194</ArticleId></ArticleIdList></Reference><Reference><Citation>Say D., Crawford N., McNab S., Wurzel D., Steer A., Tosif S. Post-acute COVID-19 outcomes in children with mild and asymptomatic disease. Lancet Child Adolesc Health. 2021;5(6):e22&#x2013;e23. doi: 10.1016/S2352-4642(21)00124-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00124-3</ArticleId><ArticleId IdType="pmc">PMC8057863</ArticleId><ArticleId IdType="pubmed">33891880</ArticleId></ArticleIdList></Reference><Reference><Citation>Brackel C.L.H., Lap C.R., Buddingh E.P., et al. Pediatric long-COVID: an overlooked phenomenon? Pediatr Pulmonol. 2021;56(8):2495&#x2013;2502. doi: 10.1002/ppul.25521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.25521</ArticleId><ArticleId IdType="pmc">PMC8242715</ArticleId><ArticleId IdType="pubmed">34102037</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Munblit D., De Rose C., et al. Preliminary evidence on long COVID in children. Acta Paediatr. 2021;110(7):2208&#x2013;2211. doi: 10.1111/apa.15870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15870</ArticleId><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Zavala M., Ireland G., Amin-Chowdhury Z., Ramsay M.E., Ladhani S.N. Acute and persistent symptoms in children with polymerase Chain reaction (PCR)-Confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection compared with test-negative children in England: active, prospective, national surveillance. Clin Infect Dis. 2022;75(1):e191&#x2013;e200. doi: 10.1093/cid/ciab991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab991</ArticleId><ArticleId IdType="pmc">PMC8767867</ArticleId><ArticleId IdType="pubmed">34849658</ArticleId></ArticleIdList></Reference><Reference><Citation>Radtke T., Ulyte A., Puhan M.A., Kriemler S. Long-term symptoms after SARS-CoV-2 infection in children and adolescents. JAMA. 2021;326(9):869&#x2013;871. doi: 10.1001/jama.2021.11880.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.11880</ArticleId><ArticleId IdType="pmc">PMC8283661</ArticleId><ArticleId IdType="pubmed">34264266</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Sante G., Buonsenso D., De Rose C., et al. Immune profile of children with post-acute sequelae of SARS-CoV-2 infection (Long Covid) medRxiv. 2021 doi: 10.1101/2021.05.07.21256539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.07.21256539</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Pujol F.E., Munblit D., Pata D., McFarland S., Simpson F.K. Clinical characteristics, activity levels and mental health problems in children with long coronavirus disease: a survey of 510 children. Future Microbiol. 2022;17(8):577&#x2013;588. doi: 10.2217/fmb-2021-0285.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2021-0285</ArticleId><ArticleId IdType="pmc">PMC9248023</ArticleId><ArticleId IdType="pubmed">35360923</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoke L., Schlegtendal A., Maier C., Eitner L., L&#xfc;cke T., Brinkmann F. Pulmonary function and long-term respiratory symptoms in children and adolescents after COVID-19. Front Pediatr. 2022;10 doi: 10.3389/fped.2022.851008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.851008</ArticleId><ArticleId IdType="pmc">PMC9081758</ArticleId><ArticleId IdType="pubmed">35547532</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov I.M., Spiridonova E., Bobkova P., et al. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study. Eur Respir J. 2022;59 doi: 10.1183/13993003.01341-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01341-2021</ArticleId><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Atchison C.J., Whitaker M., Donnelly C.A., et al. Characteristics and predictors of persistent symptoms post-COVID-19 in children and young people: a large community cross-sectional study in England. Arch Dis Child Epub. 2023 doi: 10.1136/archdischild-2022-325152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2022-325152</ArticleId><ArticleId IdType="pmc">PMC10313975</ArticleId><ArticleId IdType="pubmed">36863848</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahn L.M., Manny E., Mamede F., et al. Post&#x2013;COVID-19 condition in children. JAMA Pediatr. 2023;177(11):1226&#x2013;1228. doi: 10.1001/jamapediatrics.2023.3239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2023.3239</ArticleId><ArticleId IdType="pmc">PMC10507591</ArticleId><ArticleId IdType="pubmed">37721744</ArticleId></ArticleIdList></Reference><Reference><Citation>Blankenburg J., Wekenborg M.K., Reichert J., et al. Comparison of mental health outcomes in seropositive and seronegative adolescents during the COVID19 pandemic. Sci Rep. 2022;12:2246. doi: 10.1038/s41598-022-06166-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-06166-y</ArticleId><ArticleId IdType="pmc">PMC8831534</ArticleId><ArticleId IdType="pubmed">35145161</ArticleId></ArticleIdList></Reference><Reference><Citation>Leftin Dobkin S.C., Collaco J.M., McGrath-Morrow S.A. Protracted respiratory findings in children post-SARS-CoV-2 infection. Pediatr Pulmonol. 2021;56(12):3682&#x2013;3687. doi: 10.1002/ppul.25671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.25671</ArticleId><ArticleId IdType="pmc">PMC8662194</ArticleId><ArticleId IdType="pubmed">34534416</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusetsky Y., Meytel I., Mokoyan Z., Fisenko A., Babayan A., Malyavina U. Smell status in children infected with SARS-CoV-2. Laryngoscope. 2021;131(8):E2475&#x2013;E2480. doi: 10.1002/lary.29403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.29403</ArticleId><ArticleId IdType="pmc">PMC8013292</ArticleId><ArticleId IdType="pubmed">33443298</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Pinto Pereira S.M., Shafran R., et al. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study. Lancet Child Adolesc Health. 2022;6(4):230&#x2013;239. doi: 10.1016/S2352-4642(22)00022-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00022-0</ArticleId><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikkenborg Berg S., Dam Nielsen S., Nygaard U., et al. A&#xa0;long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study. Lancet Child Adolesc Health. 2022;6(4):240&#x2013;248. doi: 10.1016/S2352-4642(22)00004-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00004-9</ArticleId><ArticleId IdType="pmc">PMC8820960</ArticleId><ArticleId IdType="pubmed">35143771</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvakumar J., Havdal L.B., Drevvatne M., et al. Prevalence and characteristics associated with post-COVID-19 condition among nonhospitalized adolescents and young adults. JAMA Netw Open. 2023;6(3) doi: 10.1001/jamanetworkopen.2023.5763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.5763</ArticleId><ArticleId IdType="pmc">PMC10064252</ArticleId><ArticleId IdType="pubmed">36995712</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakurada Y., Otsuka Y., Tokumasu K., et al. Trends in long COVID symptoms in Japanese teenage patients. Medicina. 2023;59(2):261. doi: 10.3390/medicina59020261.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina59020261</ArticleId><ArticleId IdType="pmc">PMC9964697</ArticleId><ArticleId IdType="pubmed">36837463</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller F., Nguyen D.V., Navaratnam A.M., et al. Prevalence and characteristics of persistent symptoms in children during the COVID-19 pandemic: evidence from a household cohort study in England and Wales. Pediatr Infect Dis J. 2022;41(12):979&#x2013;984. doi: 10.1097/INF.0000000000003715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003715</ArticleId><ArticleId IdType="pmc">PMC9645448</ArticleId><ArticleId IdType="pubmed">36375098</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen M., Asprusten T.T., Godang K., et al. Predictors of chronic fatigue in adolescents six months after acute Epstein-Barr virus infection: A prospective cohort study. Brain Behav Immun. 2019;75:94&#x2013;100. doi: 10.1016/j.bbi.2018.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2018.09.023</ArticleId><ArticleId IdType="pubmed">30261303</ArticleId></ArticleIdList></Reference><Reference><Citation>Teeratakulpisarn J., Pientong C., Ekalaksananan T., Ruangsiripiyakul H., Uppala R. Rhinovirus infection in children hospitalized with acute bronchiolitis and its impact on subsequent wheezing or asthma: a comparison of etiologies. Asian Pac J Allergy Immunol. 2014;32(3):226&#x2013;234. doi: 10.12932/AP0417.32.3.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.12932/AP0417.32.3.2014</ArticleId><ArticleId IdType="pubmed">25268340</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukkarinen M., Koistinen A., Turunen R., Lehtinen P., Vuorinen T., Jartti T. Rhinovirus-induced first wheezing episode predicts atopic but not nonatopic asthma at school age. J&#xa0;Allergy Clin Immunol. 2017;140(4):988&#x2013;995. doi: 10.1016/j.jaci.2016.12.991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2016.12.991</ArticleId><ArticleId IdType="pmc">PMC7172285</ArticleId><ArticleId IdType="pubmed">28347734</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumas O., Hasegawa K., Mansbach J.M., Sullivan A.F., Piedra P.A., Camargo C.A., Jr. Severe bronchiolitis profiles and risk of recurrent wheeze by age 3 years. J&#xa0;Allergy Clin Immunol. 2019;143(4):1371&#x2013;1379.e7. doi: 10.1016/j.jaci.2018.08.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2018.08.043</ArticleId><ArticleId IdType="pmc">PMC6422772</ArticleId><ArticleId IdType="pubmed">30240701</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemanske R.F., Jr., Jackson D.J., Gangnon R.E., et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J&#xa0;Allergy Clin Immunol. 2005;116(3):571&#x2013;577. doi: 10.1016/j.jaci.2005.06.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2005.06.024</ArticleId><ArticleId IdType="pubmed">16159626</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunderi J.O.G., Rolfsjord L.B., Carlsen K.C.L., et al. Virus, allergic sensitisation and cortisol in infant bronchiolitis and risk of early asthma. ERJ Open Res. 2020;6(1):268&#x2013;2019. doi: 10.1183/23120541.00268-2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00268-2019</ArticleId><ArticleId IdType="pmc">PMC7073413</ArticleId><ArticleId IdType="pubmed">32201686</ArticleId></ArticleIdList></Reference><Reference><Citation>Koopmans M.P., Goosen E.S., Lima A.A., et al. Association of torovirus with acute and persistent diarrhea in children. Pediatr Infect Dis J. 1997;16(5):504&#x2013;507. doi: 10.1097/00006454-199705000-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-199705000-00010</ArticleId><ArticleId IdType="pubmed">9154546</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia J., Chia A., Voeller M., Lee T., Chang R. Acute enterovirus infection followed by myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and viral persistence. J&#xa0;Clin Pathol. 2010;63(2):165&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">19828908</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Neal A.J., Hanson M.R. The enterovirus theory of disease etiology in myalgic encephalomyelitis/chronic fatigue syndrome: a critical review. Front Med. 2021;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8253308</ArticleId><ArticleId IdType="pubmed">34222292</ArticleId></ArticleIdList></Reference><Reference><Citation>Muir P., Nicholson F., Banatvala J.E., Bingley P.J. Coxsackie B virus and postviral fatigue syndrome. BMJ. 1991;302(6777):658&#x2013;659.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1675464</ArticleId><ArticleId IdType="pubmed">1849432</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition</Citation></Reference><Reference><Citation>Afrin L.B., Weinstock L.B., Molderings G.J. COVID-19 hyperinflammation and post-COVID-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis. 2020;100:327&#x2013;332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj S.R., Arnold A.C., Barboi A., et al. Long-COVID postural tachycardia syndrome: an American Autonomic Society statement. Clin Auton Res. 2021;31(3):365&#x2013;368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7976723</ArticleId><ArticleId IdType="pubmed">33740207</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P., Tian D. Bibliometric analysis of global scientific research on COVID-19. J&#xa0;Biosaf Biosecur. 2021;3(1):4&#x2013;9. doi: 10.1016/j.jobb.2020.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jobb.2020.12.002</ArticleId><ArticleId IdType="pmc">PMC7825845</ArticleId><ArticleId IdType="pubmed">33521590</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Fresneda M.A., Jim&#xe9;nez-Contreras E., Ruiz-Fresneda C., Ruiz-P&#xe9;rez R. Bibliometric analysis of international scientific production on pharmacologic treatments for SARS-CoV-2/COVID-19 during 2020. Front Public Health. 2022;9 doi: 10.3389/fpubh.2021.778203.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.778203</ArticleId><ArticleId IdType="pmc">PMC8811030</ArticleId><ArticleId IdType="pubmed">35127621</ArticleId></ArticleIdList></Reference><Reference><Citation>https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/</Citation></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F., et al. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Rytter M.J.H. Difficult questions about long COVID in children. Lancet Child Adolesc Health. 2022 Sep;6(9):595&#x2013;597. doi: 10.1016/S2352-4642(22)00167-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00167-5</ArticleId><ArticleId IdType="pmc">PMC9221929</ArticleId><ArticleId IdType="pubmed">35752193</ArticleId></ArticleIdList></Reference><Reference><Citation>Cvejic E., Lemon J., Hickie I.B., Lloyd A.R., Vollmer-Conna U. Neurocognitive disturbances associated with acute infectious mononucleosis, Ross River fever and Q fever: a preliminary investigation of inflammatory and genetic correlates. Brain Behav Immun. 2014;36:207&#x2013;214. doi: 10.1016/j.bbi.2013.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2013.11.002</ArticleId><ArticleId IdType="pubmed">24211375</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett B.K., Hickie I.B., Quigley B., et al. The relationship between fatigue, psychological and immunological variables in acute infectious illness. Aust N Z J Psychiatry. 1998;32(2):180&#x2013;186. doi: 10.3109/00048679809062727.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00048679809062727</ArticleId><ArticleId IdType="pubmed">9588296</ArticleId></ArticleIdList></Reference><Reference><Citation>Don&#xe0; D., Minotti C., Costenaro P., Da Dalt L., Giaquinto C. Fecal-oral transmission of SARS-CoV-2 in children: is it time to change our approach? Pediatr Infect Dis J. 2020;39(7):e133&#x2013;e134. doi: 10.1097/INF.0000000000002704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002704</ArticleId><ArticleId IdType="pmc">PMC7279053</ArticleId><ArticleId IdType="pubmed">32304466</ArticleId></ArticleIdList></Reference><Reference><Citation>Freedberg D.E., Chang L. Gastrointestinal symptoms in COVID-19: the long and the short of it. Curr Opin Gastroenterol. 2022;38(6):555&#x2013;561. doi: 10.1097/MOG.0000000000000876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOG.0000000000000876</ArticleId><ArticleId IdType="pubmed">36165028</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalziel S.R., Haskell L., O'Brien S., et al. Bronchiolitis. Lancet. 2022;400(10349):392&#x2013;406. doi: 10.1016/S0140-6736(22)01016-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01016-9</ArticleId><ArticleId IdType="pubmed">35785792</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z., Kang H., Li S., Zhao X. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J&#xa0;Neurol. 2020 Aug;267(8):2179&#x2013;2184. doi: 10.1007/s00415-020-09929-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09929-7</ArticleId><ArticleId IdType="pmc">PMC7249973</ArticleId><ArticleId IdType="pubmed">32458193</ArticleId></ArticleIdList></Reference><Reference><Citation>Veleri S. Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients. Exp Brain Res. 2022;240(1):9&#x2013;25. doi: 10.1007/s00221-021-06244-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00221-021-06244-z</ArticleId><ArticleId IdType="pmc">PMC8543422</ArticleId><ArticleId IdType="pubmed">34694467</ArticleId></ArticleIdList></Reference><Reference><Citation>Igbokwe V., Ruby L.C., Sultanli A., B&#xe9;lard S. Post-tuberculosis sequelae in children and adolescents: a systematic review. Lancet Infect Dis. 2023;23(4):e138&#x2013;e150. doi: 10.1016/S1473-3099(23)00004-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00004-X</ArticleId><ArticleId IdType="pubmed">36963920</ArticleId></ArticleIdList></Reference><Reference><Citation>Guleid F.H., Oyando R., Kabia E., et al. A&#xa0;bibliometric analysis of COVID-19 research in Africa. BMJ Glob Health. 2021;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8111873</ArticleId><ArticleId IdType="pubmed">33972261</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>